Literature DB >> 21148601

International consensus for a definition of disease flare in lupus.

N Ruperto1, L M Hanrahan, G S Alarcón, H M Belmont, R L Brey, P Brunetta, J P Buyon, M I Costner, M E Cronin, M A Dooley, G Filocamo, D Fiorentino, P R Fortin, A G Franks, G Gilkeson, E Ginzler, C Gordon, J Grossman, B Hahn, D A Isenberg, K C Kalunian, M Petri, L Sammaritano, J Sánchez-Guerrero, R D Sontheimer, V Strand, M Urowitz, J M von Feldt, V P Werth, J T Merrill.   

Abstract

The Lupus Foundation of America (LFA) convened an international working group to obtain a consensus definition of disease flare in lupus. With help from the Paediatric Rheumatology International Trials Organization (PRINTO), two web-based Delphi surveys of physicians were conducted. Subsequently, the LFA held a second consensus conference followed by a third Delphi survey to reach a community-wide agreement for flare definition. Sixty-nine of the 120 (57.5%) polled physicians responded to the first survey. Fifty-nine of the responses were available to draft 12 preliminary statements, which were circulated in the second survey. Eighty-seven of 118 (74%) physicians completed the second survey, with an agreement of 70% for 9/12 (75%) statements. During the second conference, three alternative flare definitions were consolidated and sent back to the international community. One hundred and sixteen of 146 (79.5%) responded, with agreement by 71/116 (61%) for the following definition: "A flare is a measurable increase in disease activity in one or more organ systems involving new or worse clinical signs and symptoms and/or laboratory measurements. It must be considered clinically significant by the assessor and usually there would be at least consideration of a change or an increase in treatment." The LFA proposes this definition for lupus flare on the basis of its high face validity.

Mesh:

Year:  2010        PMID: 21148601     DOI: 10.1177/0961203310388445

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  50 in total

1.  Psychometric validation of the Arthritis Helplessness Index in systemic lupus erythematosus.

Authors:  S Gholizadeh; D R Azizoddin; S D Mills; G Zamora-Racaza; H M K Potemra; D J Wallace; M H Weisman; P M Nicassio
Journal:  Lupus       Date:  2018-08-15       Impact factor: 2.911

Review 2.  Top 10 things to know about lupus activity measures.

Authors:  Aikaterini Thanou; Joan T Merrill
Journal:  Curr Rheumatol Rep       Date:  2013-06       Impact factor: 4.592

3.  4G/5G plasminogen activator inhibitor-1 and -308 A/G tumor necrosis factor-α promoter gene polymorphisms in Argentinean lupus patients: focus on lupus nephritis.

Authors:  Sebastián Andrés Muñoz; Federico Aranda; Alberto Allievi; Alberto Omar Orden; Silvia Perés Wingeyer; Rosana Trobo; Analía Alvarez; Alicia Eimon; Juan Carlos Barreira; Emilce Schneeberger; Fernando Dal Pra; Judith Sarano; Julio Hofman; Julián Chamorro; Gabriela de Larrañaga
Journal:  Clin Exp Med       Date:  2012-11-11       Impact factor: 3.984

4.  Pregnancy outcomes in women with childhood-onset and adult-onset systemic lupus erythematosus: a comparative study.

Authors:  Miguel Ángel Saavedra; Dafhne Miranda-Hernández; Antonio Sánchez; Sara Morales; Pilar Cruz-Domínguez; Gabriela Medina; Luis Javier Jara
Journal:  Rheumatol Int       Date:  2016-07-07       Impact factor: 2.631

5.  Hypertensive disorders of pregnancy associated with adverse pregnant outcomes in patients with systemic lupus erythematosus: a multicenter retrospective study.

Authors:  Dongying Chen; Minxi Lao; Xiaoyan Cai; Hao Li; Yanfeng Zhan; Xiaodong Wang; Zhongping Zhan
Journal:  Clin Rheumatol       Date:  2019-08-03       Impact factor: 2.980

6.  How should lupus flares be measured? Deconstruction of the safety of estrogen in lupus erythematosus national assessment-systemic lupus erythematosus disease activity index flare index.

Authors:  Aikaterini Thanou; Eliza Chakravarty; Judith A James; Joan T Merrill
Journal:  Rheumatology (Oxford)       Date:  2014-04-11       Impact factor: 7.580

7.  Turkish lupusPRO: cross-cultural validation study for lupus.

Authors:  Arif Kaya; Berna Goker; Elife Senem Cura; Mehmet Engin Tezcan; Abdurrahman Tufan; Rıdvan Mercan; Berivan Bitik; Seminur Haznedaroglu; Mehmet Akif Ozturk; Rachel A Mikolaitis-Preuss; Joel A Block; Meenakshi Jolly
Journal:  Clin Rheumatol       Date:  2013-08-11       Impact factor: 2.980

Review 8.  Defining neonatal sepsis.

Authors:  James L Wynn
Journal:  Curr Opin Pediatr       Date:  2016-04       Impact factor: 2.856

Review 9.  Leveraging Heterogeneity in Systemic Lupus Erythematosus for New Therapies.

Authors:  Marilyn E Allen; Violeta Rus; Gregory L Szeto
Journal:  Trends Mol Med       Date:  2020-10-09       Impact factor: 11.951

10.  Neutrophil to Lymphocyte Ratio and Mean Platelet Volume as Inflammatory Indicators in Systemic Lupus Erythematosus Nephritis.

Authors:  Ata Bora Ayna; Selime Ermurat; Belkis Nihan Coşkun; Halil Harman; Yavuz Pehlivan
Journal:  Arch Rheumatol       Date:  2016-08-17       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.